Leading the Future of AI in Cancer Science
Advancing AI in Cancer Research
Explore ICAIRI’s pioneering efforts in harnessing artificial intelligence to revolutionize cancer research, from computational methods to clinical applications.
Our Flagship Journal: Anticancer Intelligence
ICAIRI’s primary publication vehicle is the Anticancer Intelligence, a peer-reviewed, open-access journal dedicated to advancing rigorous research at the intersection of artificial intelligence and oncology. Anticancer Intelligence publishes original research, methodological papers, validation studies, and clinical applications across six thematic sections spanning AI methods, cancer genomics, imaging, drug discovery, and clinical decision support. By providing researchers and clinicians with a dedicated venue for AI-oncology work, Anticancer Intelligence accelerates knowledge translation, supports evidence-based algorithm deployment, and connects computational innovation with translational cancer research. All articles are freely available under CC BY 4.0 licensing and registered with Crossref for global discoverability.
Explore Anticancer Intelligence | Submission Guidelines | Current Issues
Pioneering AI to Transform Cancer Research and Treatment
The International Cancer Artificial Intelligence Research Institute is dedicated to leveraging advanced AI technologies to accelerate breakthroughs in cancer research. Our mission is to develop cutting-edge computational tools that empower drug discovery and enhance clinical decisions, driving meaningful progress in oncology worldwide.
Advancing Cancer Research Through Artificial Intelligence
Explore pioneering AI tools designed to accelerate breakthroughs in oncology research.
Computational Methods
Understand core AI algorithms driving cancer data analysis and insights.
Drug Discovery
Investigate novel AI techniques transforming anticancer drug development.
Clinical Decision Support
Gain insights into AI systems enhancing oncologists’ treatment planning.